Description

n-(1,3-Benzothiazol-2-Yl)-2-[3-(4-Fluorophenyl)-6-Oxopyridazin-1(6H)-Yl]Acetamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound matters for its role as a critical building block in modern medicinal chemistry, enabling the development of targeted therapies. It is primarily needed by R&D laboratories and production facilities in the pharmaceutical and biotechnology sectors, particularly those focused on developing new small-molecule drugs.

Application

This specialized intermediate is engineered for high-value synthesis applications. Key uses include:

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in therapeutic areas requiring complex heterocyclic scaffolds.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new bioactive molecules.
• API Development: Serves as a critical building block in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs).
• Biochemical Research: Employed in the development of chemical probes and inhibitors for studying biological pathways and target validation.
• Custom Synthesis: Utilized by contract research and manufacturing organizations (CROs/CMOs) for client-specific molecule production.

Basic Information

Product Name	n-(1,3-Benzothiazol-2-Yl)-2-[3-(4-Fluorophenyl)-6-Oxopyridazin-1(6H)-Yl]Acetamide
CAS No.	922994-01-2
Molecular Formula	C21H15FN4O2S
Molecular Weight	406.43 g/mol
Synonyms	2-({3-(4-Fluorophenyl)-6-oxo-6H-pyridazin-1-yl}acetyl)-N-(1,3-benzothiazol-2-yl)acetamide; N-(Benzothiazol-2-yl)-2-[3-(4-fluorophenyl)-6-oxopyridazin-1(6H)-yl]acetamide; 922994-01-2; Acetamide, N-(2-benzothiazolyl)-2-[3-(4-fluorophenyl)-6-oxo-1(6H)-pyridazinyl]-; BTA-FPPA intermediate
EINECS	Contact for details

Quality Control

Our n-(1,3-Benzothiazol-2-Yl)-2-[3-(4-Fluorophenyl)-6-Oxopyridazin-1(6H)-Yl]Acetamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all specified parameters. Our quality commitment aligns with the standards expected for pharmaceutical development, including ICH guidelines for impurities.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability. Keep the container tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Single Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.